Search

everythinglearnresearchcommunity

for

Search:↓

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

JAK inhibitors show promise in treating difficult skin diseases.

A man developed skin issues from cancer medication, which improved with specific treatments.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Two impurities in finasteride were identified and characterized as cyclohexyl and phenyl analogs.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

JAK inhibitors show promise for treating various skin diseases.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

The compound was successfully made and shows potential for treating prostate cancer.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Blocking YAP/TAZ could be a new way to treat skin cancer.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Cilostazol may help hair grow and could be a new treatment for hair loss.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.